This Newly Approved Narcolepsy Drug Is the First to Target the Sleep Disorder's Root Cause Rather Than Its Symptoms

The Food and Drug Administration just greenlit a medication called Orzeyful for the treatment of narcolepsy type 1 in adults. The condition is caused by the loss of brain cells that produce orexin, a chemical important for regulating the sleep-wake cycle

Read it at Smithsonian Smart News ↗

← Front page